Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > RET(Gene name) > Human
  • Add your favorite
  • RET (Gene name),
  • Proto-oncogene tyrosine-protein kinase receptor Ret (Protein name ),  RET_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    RET(CDHF12;CDHR16;PTC;RET51);
    Protein name:
    Proto-oncogene tyrosine-protein kinase receptor Ret;
    Alternative:
    Proto-oncogene c-Ret;Cadherin family member 12;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Phosphorylated form interacts with the PBT domain of DOK2, DOK4 and DOK5. The phosphorylated form interacts with PLCG1 and GRB7.
    Function:
    Probable receptor with tyrosine-protein kinase activity; important for development.
    Subcellular Location:
    Membrane Single-pass type I membrane protein
    Protein Attributes:
    Sequence length:
    1114
    Sequence:
    50:
    MAKATSGAAG | LRLLLLLLLP | LLGKVALGLY | FSRDAYWEKL | YVDQAAGTPL | 
    100:
    LYVHALRDAP | EEVPSFRLGQ | HLYGTYRTRL | HENNWICIQE | DTGLLYLNRS | 
    150:
    LDHSSWEKLS | VRNRGFPLLT | VYLKVFLSPT | SLREGECQWP | GCARVYFSFF | 
    200:
    NTSFPACSSL | KPRELCFPET | RPSFRIRENR | PPGTFHQFRL | LPVQFLCPNI | 
    250:
    SVAYRLLEGE | GLPFRCAPDS | LEVSTRWALD | REQREKYELV | AVCTVHAGAR | 
    300:
    EEVVMVPFPV | TVYDEDDSAP | TFPAGVDTAS | AVVEFKRKED | TVVATLRVFD | 
    350:
    ADVVPASGEL | VRRYTSTLLP | GDTWAQQTFR | VEHWPNETSV | QANGSFVRAT | 
    400:
    VHDYRLVLNR | NLSISENRTM | QLAVLVNDSD | FQGPGAGVLL | LHFNVSVLPV | 
    450:
    SLHLPSTYSL | SVSRRARRFA | QIGKVCVENC | QAFSGINVQY | KLHSSGANCS | 
    500:
    TLGVVTSAED | TSGILFVNDT | KALRRPKCAE | LHYMVVATDQ | QTSRQAQAQL | 
    550:
    LVTVEGSYVA | EEAGCPLSCA | VSKRRLECEE | CGGLGSPTGR | CEWRQGDGKG | 
    600:
    ITRNFSTCSP | STKTCPDGHC | DVVETQDINI | CPQDCLRGSI | VGGHEPGEPR | 
    650:
    GIKAGYGTCN | CFPEEEKCFC | EPEDIQDPLC | DELCRTVIAA | AVLFSFIVSV | 
    700:
    LLSAFCIHCY | HKFAHKPPIS | SAEMTFRRPA | QAFPVSYSSS | GARRPSLDSM | 
    750:
    ENQVSVDAFK | ILEDPKWEFP | RKNLVLGKTL | GEGEFGKVVK | ATAFHLKGRA | 
    800:
    GYTTVAVKML | KENASPSELR | DLLSEFNVLK | QVNHPHVIKL | YGACSQDGPL | 
    850:
    LLIVEYAKYG | SLRGFLRESR | KVGPGYLGSG | GSRNSSSLDH | PDERALTMGD | 
    900:
    LISFAWQISQ | GMQYLAEMKL | VHRDLAARNI | LVAEGRKMKI | SDFGLSRDVY | 
    950:
    EEDSYVKRSQ | GRIPVKWMAI | ESLFDHIYTT | QSDVWSFGVL | LWEIVTLGGN | 
    1000:
    PYPGIPPERL | FNLLKTGHRM | ERPDNCSEEM | YRLMLQCWKQ | EPDKRPVFAD | 
    1050:
    ISKDLEKMMV | KRRDYLDLAA | STPSDSLIYD | DGLSEEETPL | VDCNNAPLPR | 
    1100:
    ALPSTWIENK | LYGMSDPNWP | GESPVPLTRA | DGTNTGFPRY | PNDSVYANWM | 
    1114:
    LSPSAAKLMD | TFDS
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    KEGG:
    String:
    Pfam:
    SMR:
    UniGene:
    MIM:
    Uniprot:
     
    FOR
    ELISA Kit for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Cat.:
    E15070h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Cat.:
    E15070r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    MSDS:
    Please sign in first.
    CLIA Kit for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    MSDS:
    Please sign in first.
    CLIA Kit for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    MSDS:
    Please sign in first.
    CLIA Kit for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Cat.:
    U15070h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Polyclonal Antibody for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Polyclonal Antibody for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Monoclonal Antibody for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Monoclonal Antibody for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Monoclonal Antibody for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Protein for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Protein for Human Proto-oncogene tyrosine-protein kinase receptor Ret
    Protein for Human Proto-oncogene tyrosine-protein kinase receptor Ret

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)
      tissue: Prostate.
    2. 2.
      "The DNA sequence and comparative analysis of human chromosome 10."
      Deloukas P. , Earthrowl M.E. , Grafham D.V. , Rubenfield M. , French L. , Steward C.A. , Sims S.K. , Jones M.C. , Searle S. , Scott C. , Howe K. , Hunt S.E. , Andrews T.D. , Gilbert J.G.R. , Swarbreck D. , Ashurst J.L. , Taylor A. , Battles J. , more...
      Nature429:375-381(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    3. 3.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2);VARIANT CYS-982
      tissue: Brain.
    4. 4.
      "Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence."
      Takahashi M.
      Oncogene4:805-806(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-280 (ISOFORMS 1/2)
    5. 5.
      "Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains."
      Takahashi M. , Buma Y. , Iwamoto T. , Inaguma Y. , Ikeda H. , Hiai H.
      Oncogene3:571-578(1988) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 255-1114 (ISOFORM 1)
    6. 6.
      "ret transforming gene encodes a fusion protein homologous to tyrosine kinases."
      Takahashi M. , Cooper G.M.
      Mol. Cell. Biol.7:1378-1385(1987) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 588-1063 (ISOFORM 2);CHROMOSOMAL TRANSLOCATION WITH TRIM27
    7. 7.
      "Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing."
      Ishizaka Y. , Ochiai M. , Tahira T. , Suhimura T. , Nahao M.
      Oncogene4:789-794(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 713-1114 (ISOFORM 1);CHROMOSOMAL TRANSLOCATION WITH GOLGA5
      tissue: Fibroblast.
    8. 8.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM
    9. 9.
      "PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas."
      Grieco M. , Santoro M. , Berlingieri M.T. , Melillo R.M. , Donghi R. , Bongarzone I. , Pierotti M.A. , Della Porta G. , Fusco A. , Vecchio G.
      Cell60:557-563(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 713-1114 (ISOFORM 1);CHROMOSOMAL TRANSLOCATION WITH CCDC6
      tissue: Thyroid papillary carcinoma.
    10. 10.
      "RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma."
      Corvi R. , Berger N. , Balczon R. , Romeo G.
      Oncogene19:4236-4242(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 713-770 (ISOFORMS 1/2);CHROMOSOMAL TRANSLOCATION WITH PCM1
    11. 11.
      "The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas."
      Klugbauer S. , Rabes H.M.
      Oncogene18:4388-4393(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHROMOSOMAL TRANSLOCATION WITH TRIM33 AND TRIM24
    12. 12.
      "Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins."
      Salvatore D. , Barone M.V. , Salvatore G. , Melillo R.M. , Chiappetta G. , Mineo A. , Fenzi G. , Vecchio G. , Fusco A. , Santoro M.
      J. Clin. Endocrinol. Metab.85:3898-3907(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT TYR-1015 AND TYR-1062
    13. 13.
      "Identification of RET autophosphorylation sites by mass spectrometry."
      Kawamoto Y. , Takeda K. , Okuno Y. , Yamakawa Y. , Ito Y. , Taguchi R. , Kato M. , Suzuki H. , Takahashi M. , Nakashima I.
      J. Biol. Chem.279:14213-14224(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT TYR-806; TYR-809; TYR-900; TYR-905; TYR-981; TYR-1015; TYR-1062; TYR-1090 AND TYR-1096
    14. 14.
      "Novel tumorigenic rearrangement, Delta rfp/ret, in a papillary thyroid carcinoma from externally irradiated patient."
      Saenko V. , Rogounovitch T. , Shimizu-Yoshida Y. , Abrosimov A. , Lushnikov E. , Roumiantsev P. , Matsumoto N. , Nakashima M. , Meirmanov S. , Ohtsuru A. , Namba H. , Tsyb A. , Yamashita S.
      Mutat. Res.527:81-90(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHROMOSOMAL TRANSLOCATION WITH TRIM27
    15. 15.
      "The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins."
      Iervolino A. , Iuliano R. , Trapasso F. , Viglietto G. , Melillo R.M. , Carlomagno F. , Santoro M. , Fusco A.
      Cancer Res.66:6280-6287(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT TYR-905; TYR-1015 AND TYR-1062;DEPHOSPHORYLATION AT TYR-905; TYR-1015 AND TYR-1062 BY PTPRJ
    16. 16.
      "The discovery of substituted 4-(3-hydroxyanilino)-quinolines as potent RET kinase inhibitors."
      Graham Robinett R. , Freemerman A.J. , Skinner M.A. , Shewchuk L. , Lackey K.
      Bioorg. Med. Chem. Lett.17:5886-5893(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION
    17. 17.
      "Sorafenib functions to potently suppress RET tyrosine kinase activity by direct enzymatic inhibition and promoting RET lysosomal degradation independent of proteasomal targeting."
      Plaza-Menacho I. , Mologni L. , Sala E. , Gambacorti-Passerini C. , Magee A.I. , Links T.P. , Hofstra R.M.W. , Barford D. , Isacke C.M.
      J. Biol. Chem.282:29230-29240(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION BY SORAFENIB
    18. 18.
      "Synthesis, modeling, and RET protein kinase inhibitory activity of 3- and 4-substituted beta-carbolin-1-ones."
      Cincinelli R. , Cassinelli G. , Dallavalle S. , Lanzi C. , Merlini L. , Botta M. , Tuccinardi T. , Martinelli A. , Penco S. , Zunino F.
      J. Med. Chem.51:7777-7787(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION BY 3- AND 4-SUBSTITUTED BETA-CARBOLIN-1-ONES
    19. 19.
      "CD2AP and Cbl-3/Cbl-c constitute a critical checkpoint in the regulation of ret signal transduction."
      Tsui C.C. , Pierchala B.A.
      J. Neurosci.28:8789-8800(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH CD2AP;MUTAGENESIS OF LYS-758
    20. 20.
      "The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability."
      Vargiolu M. , Fusco D. , Kurelac I. , Dirnberger D. , Baumeister R. , Morra I. , Melcarne A. , Rimondini R. , Romeo G. , Bonora E.
      J. Clin. Endocrinol. Metab.94:2571-2578(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH AIP
    21. 21.
      "Transcriptional regulation of RET by Nkx2-1, Phox2b, Sox10, and Pax3."
      Leon T.Y.Y. , Ngan E.S.W. , Poon H.-C. , So M.-T. , Lui V.C.H. , Tam P.K.H. , Garcia-Barcelo M.M.
      J. Pediatr. Surg.44:1904-1912(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INDUCTION BY NKX2-1; PHOX2B; SOX10 AND PAX3
    22. 22.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-696;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    23. 23.
      "RETouching upon mechanoreceptors."
      Ma Q.
      Neuron64:773-776(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN DEVELOPMENT OF MECHANORECEPTORS
    24. 24.
      "The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors."
      Ye L. , Santarpia L. , Gagel R.F.
      Endocr. Rev.31:578-599(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION;REVIEW ON KINASE INHIBITORS
    25. 25.
      "Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl)nicotinonitrile scaffold."
      Brandt W. , Mologni L. , Preu L. , Lemcke T. , Gambacorti-Passerini C. , Kunick C.
      Eur. J. Med. Chem.45:2919-2927(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION
    26. 26.
      "Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary."
      Garcia-Lavandeira M. , Diaz-Rodriguez E. , Garcia-Rendueles M.E. , Rodrigues J.S. , Perez-Romero S. , Bravo S.B. , Alvarez C.V.
      Front. Horm. Res.38:127-138(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN PITUITARY
    27. 27.
      "RET-mediated cell adhesion and migration require multiple integrin subunits."
      Cockburn J.G. , Richardson D.S. , Gujral T.S. , Mulligan L.M.
      J. Clin. Endocrinol. Metab.95:E342-E346(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CELL ADHESION/MIGRATION
    28. 28.
      "Direct visualization of vesicle maturation and plasma membrane protein trafficking."
      Richardson D.S. , Mulligan L.M.
      J. Fluoresc.20:401-405(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION
    29. 29.
      "A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo."
      Samadi A.K. , Mukerji R. , Shah A. , Timmermann B.N. , Cohen M.S.
      Surgery148:1228-1236(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION
    30. 30.
      "RET modulates cell adhesion via its cleavage by caspase in sympathetic neurons."
      Cabrera J.R. , Bouzas-Rodriguez J. , Tauszig-Delamasure S. , Mehlen P.
      J. Biol. Chem.286:14628-14638(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CELL ADHESION;FUNCTION IN APOPTOSIS;PROTEOLYTIC PROCESSING BY CASPASE-3 AT ASP-707 AND ASP-1017;MUTAGENESIS OF ASP-707; LYS-758 AND 708-ALA--SER-1114;SUBUNIT
    31. 31.
      "Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism."
      Plaza-Menacho I. , Morandi A. , Mologni L. , Boender P. , Gambacorti-Passerini C. , Magee A.I. , Hofstra R.M.W. , Knowles P. , McDonald N.Q. , Isacke C.M.
      J. Biol. Chem.286:17292-17302(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH PTK2/FAK1;FUNCTION IN PTK2/FAK1 PHOSPHORYLATION
    32. 32.
      "Structure and chemical inhibition of the RET tyrosine kinase domain."
      Knowles P.P. , Murray-Rust J. , Kjaer S. , Scott R.P. , Hanrahan S. , Santoro M. , Ibanez C.F. , McDonald N.Q.
      J. Biol. Chem.281:33577-33587(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 705-1013 ALONE AND IN COMPLEX WITH INHIBITORS;IDENTIFICATION BY MASS SPECTROMETRY;PHOSPHORYLATION AT TYR-900 AND TYR-905
    33. 33.
      "Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors."
      Mologni L. , Rostagno R. , Brussolo S. , Knowles P.P. , Kjaer S. , Murray-Rust J. , Rosso E. , Zambon A. , Scapozza L. , McDonald N.Q. , Lucchini V. , Gambacorti-Passerini C.
      Bioorg. Med. Chem.18:1482-1496(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 705-1013 IN COMPLEX WITH INHIBITORS;ENZYME REGULATION;PHOSPHORYLATION AT TYR-905
    34. 34.
      "Mammal-restricted elements predispose human RET to folding impairment by HSCR mutations."
      Kjaer S. , Hanrahan S. , Totty N. , McDonald N.Q.
      Nat. Struct. Mol. Biol.17:726-731(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 29-270;GLYCOSYLATION AT ASN-151;DISULFIDE BOND
    35. 35.
      "Mutations in Hirschsprung disease: when does a mutation contribute to the phenotype."
      Hofstra R.M.W. , Osinga J. , Buys C.H.C.M.
      Eur. J. Hum. Genet.5:180-185(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON HSCR VARIANTS
    36. 36.
      "Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease."
      Eng C. , Mulligan L.M.
      Hum. Mutat.9:97-109(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON VARIANTS
    37. 37.
      "Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC."
      Donis-Keller H. , Dou S. , Chi D. , Carlson K.M. , Toshima K. , Lairmore T.C. , Howe J.R. , Moley J.F. , Goodfellow P. , Wells S.A. Jr.
      Hum. Mol. Genet.2:851-856(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MEN2A/MTC TRP-611; SER-618; ARG-620; TYR-620 AND ARG-634
    38. 38.
      "Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A."
      Mulligan L.M. , Kwok J.B.J. , Healey C.S. , Elsdon M.J. , Eng C. , Gardner E. , Love D.R. , Mole S.E. , Moore J.K. , Papi L. , Ponder M.A. , Telenius H. , Tunnacliffe A. , Ponder B.A.J.
      Nature363:458-460(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MEN2A GLY-618; 632-ASP--ARG-634; GLY-634; PHE-634; TYR-634 AND SER-634
    39. 39.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 PRO-40; LEU-399; GLN-762; PRO-765; GLN-897; GLY-972 AND LEU-973
    40. 40.
      "Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours."
      Eng C. , Smith D.P. , Mulligan L.M. , Nagai M.A. , Healey C.S. , Ponder M.A. , Gardner E. , Scheumann G.F. , Jackson C.E. , Tunnacliffe A. , Ponder B.A.J.
      Hum. Mol. Genet.3:237-241(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MEN2B THR-918
    41. 41.
      "Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests."
      Xue F. , Yu H. , Maurer L.H. , Memoli V.A. , Nutile-Mcmenemy N. , Schuster M.K. , Browden D.W. , Mao J.-I. , Noll W.W.
      Hum. Mol. Genet.3:635-638(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MEN2A/MTC ARG-618; SER-618; PHE-620; ARG-620; PHE-634; GLY-634 AND TYR-634
    42. 42.
      "RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer."
      Blaugrund J.E. , Johns M.M. Jr. , Eby Y.J. , Ball D.W. , Baylin S.B. , Hruban R.H. , Sidransky D.
      Hum. Mol. Genet.3:1895-1897(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MTC/MEN2A TYR-609; ARG-618; SER-618 AND SER-620
    43. 43.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MTC;VARIANTS MEN2A
    44. 44.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 TRP-609; ARG-618 AND ARG-620;VARIANT MEN2A ARG-618;VARIANT MTC ARG-620
    45. 45.
      "A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma."
      Hofstra R.M.W. , Landsvater R.M. , Ceccherini I. , Stulp R.P. , Stelwagen T. , Luo Y. , Pasini B. , Hoeppener J.W.M. , Ploos van Amstel H.K. , Romeo G. , Lips C.J.M. , Buys C.H.C.M.
      Nature367:375-376(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MEN2B THR-918
    46. 46.
      "Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease."
      Romeo G. , Ronchetto P. , Luo Y. , Barone V. , Seri M. , Ceccherini I. , Pasini B. , Bocciardi R. , Lerone M. , Kaarlainen H. , Martucciello G.
      Nature367:377-378(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 PRO-765; GLN-897 AND GLY-972
    47. 47.
      "Mutations of the RET proto-oncogene in Hirschsprung's disease."
      Edery P. , Lyonnet S. , Mulligan L.M. , Pelet A. , Dow E. , Abel L. , Holder S. , Nihoul-Fkete C. , Ponder B.A.J. , Munnich A.
      Nature367:378-380(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 LEU-32; LEU-64; GLN-330 AND LEU-393
    48. 48.
      "Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B."
      Carlson K.M. , Dou S. , Chi D. , Scavarda N. , Toshima K. , Jackson C.E. , Wells S.A. Jr. , Goodfellow P.J. , Donis-Keller H.
      Proc. Natl. Acad. Sci. U.S.A.91:1579-1583(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MEN2B THR-918
    49. 49.
      "Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas."
      Komminoth P. , Kunz E.K. , Matias-Guiu X. , Hiort O. , Christiansen G. , Colomer A. , Roth J. , Heitz P.U.
      Cancer76:479-489(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MTC; MEN2A AND MEN2B
    50. 50.
      "Germline mutations of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia type 2A (MEN2A)."
      Takiguchi-Shirahama S. , Koyama K. , Miyauchi A. , Wakasugi T. , Oishi S. , Takami H. , Hikiji K. , Nakamura Y.
      Hum. Genet.95:187-190(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MEN2A SER-618; SER-620; ARG-634 AND TYR-634
    51. 51.
      "Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease."
      Angrist M. , Bolk S. , Thiel B. , Puffenberger E.G. , Hofstra R.M.W. , Buys C.H.C.M. , Cass D.T. , Chakravarti A.
      Hum. Mol. Genet.4:821-830(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 LEU-20; SER-93; GLN-330; TYR-609 AND ARG-620;VARIANT CYS-982
      tissue: Blood.
    52. 52.
      "Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease."
      Attie T. , Pelet A. , Edery P. , Eng C. , Mulligan L.M. , Amiel J. , Boutrand L. , Beldjord C. , Nihoul-Fekete C. , Munnich A. , Ponder B.A.J. , Lyonnet S.
      Hum. Mol. Genet.4:1381-1386(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1
      tissue: Leukocyte.
    53. 53.
      "Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B."
      Kitamura Y. , Scavarda N. , Wells S.A. Jr. , Jackson C.E. , Goodfellow P.J.
      Hum. Mol. Genet.4:1987-1988(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MEN2B THR-918;VARIANT TYR-922
    54. 54.
      "A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC."
      Eng C. , Smith D.P. , Mulligan L.M. , Healey C.S. , Zvelebil M.J. , Stonehouse T.J. , Ponder M.A. , Jackson C.E. , Waterfield M.D. , Ponder B.A.J.
      Oncogene10:509-513(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MTC ASP-768
    55. 55.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MTC ASP-768 AND LEU-804
    56. 56.
      "Mutations in three genes are found associated with the development of Hirschsprung disease: RET, EDNRB and EDN3."
      Hofstra R.M.W. , Osinga J. , Stulp R.P. , Scheffer H. , Meijers C. , Buys C.H.C.M.
      Am. J. Hum. Genet.59:A263-A263(1996)
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 TYR-157; LYS-359; TYR-609; ARG-620; ASN-1059 DEL AND PRO-1061
    57. 57.
      "Prevalence and parental origin of de novo RET mutations in Hirschsprung's disease."
      Yin L. , Seri M. , Barone V. , Tocco T. , Scaranari M. , Romeo G.
      Eur. J. Hum. Genet.4:356-358(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 PRO-40 AND PRO-765
    58. 58.
      "Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A."
      Landsvater R.M. , Jansen R.P.M. , Hofstra R.M.W. , Buys C.H.C.M. , Lips C.J.M. , van Amstel H.K.P.
      Hum. Genet.97:11-14(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MTC/MEN2A
    59. 59.
      "Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations."
      Kambouris M. , Jackson C.E. , Feldman G.L.
      Hum. Mutat.8:64-70(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MEN2A;VARIANT MTC ASP-768;VARIANT MEN2B THR-918
    60. 60.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MEN2A
    61. 61.
      "A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A."
      Hoeppner W. , Ritter M.M.
      Hum. Mol. Genet.6:587-590(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MEN2A HIS-GLU-LEU-CYS-634 INS
    62. 62.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 PRO-180; GLN-313; ARG-620 AND PHE-791
    63. 63.
      "Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting."
      Peretz H. , Luboshitsky R. , Baron E. , Biton A. , Gershoni R. , Usher S. , Grynberg E. , Yakobson E. , Graff E. , Lapidot M.
      Hum. Mutat.10:155-159(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MTC ARG-618;VARIANT HSCR1 ARG-618
    64. 64.
      "Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation."
      Gimm O. , Marsh D.J. , Andrew S.D. , Frilling A. , Dahia P.L.M. , Mulligan L.M. , Zajac J.D. , Robinson B.G. , Eng C.
      J. Clin. Endocrinol. Metab.82:3902-3904(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MEN2B PHE-883
      tissue: Peripheral blood leukocyte.
    65. 65.
      "A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma."
      Hofstra R.M.W. , Fattoruso O. , Quadro L. , Wu Y. , Libroia A. , Verga U. , Colantuoni V. , Buys C.H.C.M.
      J. Clin. Endocrinol. Metab.82:4176-4178(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MTC ALA-891
    66. 66.
      "Mutation analysis of the RET, the endothelin-B receptor, and the endothelin-3 genes in sporadic cases of Hirschsprung's disease."
      Kusafuka T. , Wang Y. , Puri P.
      J. Pediatr. Surg.32:501-504(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 SER-174 AND TYR-197
    67. 67.
      "Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC."
      Kitamura Y. , Goodfellow P.J. , Shimizu K. , Nagahama M. , Ito K. , Kitagawa W. , Akasu H. , Takami H. , Tanaka S. , Wells S.A. Jr.
      Oncogene14:3103-3106(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MTC; MEN2A AND MEN2B;VARIANT SER-691
    68. 68.
      "Germline mutation of RET codon 883 in two cases of de novo MEN 2B."
      Smith D.P. , Houghton C. , Ponder B.A.J.
      Oncogene15:1213-1217(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MEN2B PHE-883
    69. 69.
      "Mutations of the RET-GDNF signaling pathway in Ondine's curse."
      Amiel J. , Salomon R. , Attie T. , Pelet A. , Trang H. , Mokhtari M. , Gaultier C. , Munnich A. , Lyonnet S.
      Am. J. Hum. Genet.62:715-717(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CCHS LEU-1039;VARIANT SER-691
    70. 70.
      "Novel point mutation in exon 10 of the RET proto-oncogene in a family with medullary thyroid carcinoma."
      Oriola J. , Paramo C. , Halperin I. , Garcia-Mayor R.V. , Rivera-Fillat F.
      Am. J. Med. Genet.78:271-273(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MTC GLY-611
    71. 71.
      "Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B)."
      Svensson P.J. , Anvret M. , Molander M.L. , Nordenskjold A.
      Hum. Genet.103:145-148(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CYS-982
    72. 72.
      "Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation."
      Decker R.A. , Peacock M.L. , Watson P.
      Hum. Mol. Genet.7:129-134(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MEN2A TYR-609; SER-618; ARG-620 AND TRP-620;VARIANTS HSCR1 TYR-609; SER-618; ARG-620 AND TRP-620
    73. 73.
      "Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A."
      Hoeppner W. , Dralle H. , Brabant G.
      Hum. Mutat. Suppl.1:S128-S130(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MEN2A CYS-ARG-THR-636 INS
    74. 74.
      "A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma."
      Fattoruso O. , Quadro L. , Libroia A. , Verga U. , Lupoli G. , Cascone E. , Colantuoni V.
      Hum. Mutat. Suppl.1:S167-S171(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MTC MET-804
    75. 75.
      "A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A."
      Berndt I. , Reuter M. , Saller B. , Frank-Raue K. , Groth P. , Grussendorf M. , Raue F. , Ritter M.M. , Hoeppner W.
      J. Clin. Endocrinol. Metab.83:770-774(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MTC/MEN2A PHE-790 AND PHE-791
    76. 76.
      "Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma."
      Shirahama S. , Ogura K. , Takami H. , Ito K. , Tohsen T. , Miyauchi A. , Nakamura Y.
      J. Hum. Genet.43:101-106(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MTC AND MEN2A
    77. 77.
      "Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease."
      Auricchio A. , Griseri P. , Carpentieri M.L. , Betsos N. , Staiano A. , Tozzi A. , Priolo M. , Thompson H. , Bocciardi R. , Romeo G. , Ballabio A. , Ceccherini I.
      Am. J. Hum. Genet.64:1216-1221(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 LYS-626 AND GLN-813
    78. 78.
      "Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site."
      Geneste O. , Bidaud C. , De Vita G. , Hofstra R.M.W. , Tartare-Deckert S. , Buys C.H.C.M. , Lenoir G.M. , Santoro M. , Billaud M.
      Hum. Mol. Genet.8:1989-1999(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 ASN-1059 DEL AND PRO-1061
    79. 79.
      "A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma."
      Pigny P. , Bauters C. , Wemeau J.-L. , Houcke M.L. , Crepin M. , Caron P. , Giraud S. , Calender A. , Buisine M.-P. , Kerckaert J.-P. , Porchet N.
      J. Clin. Endocrinol. Metab.84:1700-1704(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MTC GLU-GLU-CYS-531 INS
    80. 80.
      "A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene."
      Tessitore A. , Sinisi A.A. , Pasquali D. , Cardone M. , Vitale D. , Bellastella A. , Colantuoni V.
      J. Clin. Endocrinol. Metab.84:3522-3527(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MEN2A GLY-640
    81. 81.
      "A RET double mutation in the germline of a kindred with FMTC."
      Bartsch D.K. , Hasse C. , Schug C. , Barth P. , Rothmund M. , Hoeppner W.
      Exp. Clin. Endocrinol. Diabetes108:128-132(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MTC MET-804 AND LEU-844
    82. 82.
      "A new germline mutation, R600Q, within the coding region of RET proto-oncogene: a rare polymorphism or a MEN 2 causing mutation?"
      Saez M.E. , Ruiz A. , Cebrian A. , Morales F. , Robledo M. , Antinolo G. , Borrego S.
      Hum. Mutat.15:122-122(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GLN-600
    83. 83.
      "A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus."
      Bolk S. , Pelet A. , Hofstra R.M.W. , Angrist M. , Salomon R. , Croaker D. , Buys C.H.C.M. , Lyonnet S. , Chakravarti A.
      Proc. Natl. Acad. Sci. U.S.A.97:268-273(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 LEU-32; CYS-77; TRP-360 AND LYS-394
    84. 84.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MTC GLY-639; GLY-641 AND PHE-922
    85. 85.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS PHEOCHROMOCYTOMA ARG-634; GLY-634; TYR-634; SER-634; PHE-634; TRP-634 AND PHE-791
    86. 86.
      "Congenital central hypoventilation syndrome: a novel mutation of the RET gene in an isolated case."
      Kanai M. , Numakura C. , Sasaki A. , Shirahata E. , Akaba K. , Hashimoto M. , Hasegawa H. , Shirasawa S. , Hayasaka K.
      Tohoku J. Exp. Med.196:241-246(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CCHS HIS-114
    87. 87.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS ASN-489; SER-691 AND CYS-982;VARIANTS CCHS HIS-67; HIS-114 AND GLU-432
    88. 88.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS [LARGE SCALE ANALYSIS] GLY-145; TRP-360 AND GLU-593
    89. 89.
      "Patterns of somatic mutation in human cancer genomes."
      Greenman C. , Stephens P. , Smith R. , Dalgliesh G.L. , Hunter C. , Bignell G. , Davies H. , Teague J. , Butler A. , Stevens C. , Edkins S. , O'Meara S. , Vastrik I. , Schmidt E.E. , Avis T. , Barthorpe S. , Bhamra G. , Buck G. , more...
      Nature446:153-158(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS [LARGE SCALE ANALYSIS] GLN-163; ASN-278; MET-292; ASN-489; SER-691; THR-749; SER-826; LEU-844; CYS-982 AND TYR-1112
    90. 90.
      "Renal aplasia in humans is associated with RET mutations."
      Skinner M.A. , Safford S.D. , Reeves J.G. , Jackson M.E. , Freemerman A.J.
      Am. J. Hum. Genet.82:344-351(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS THR-198; ALA-376; HIS-394; ILE-778; SER-894; THR-918; LEU-1049 AND SER-1067;POSSIBLE INVOLVEMENT IN RENAL AGENESIS;CHARACTERIZATION OF VARIANTS THR-198; ALA-376; HIS-394; ILE-778; SER-894; LEU-1049 AND SER-1067
    91. 91.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HSCR1 549-LYS-GLY-550 DEL; CYS-114; HIS-114; GLY-145; LEU-155; PRO-175; ALA-278; PRO-278; ASN-300; GLN-313; ILE-316; LEU-339; TYR-353; GLN-360; MET-397; MET-412; ARG-423; LYS-480; GLN-595; LEU-679; GLN-694; SER-783; ARG-830; THR-907; LEU-961; VAL-1052; CYS-1062 AND THR-1064;VARIANTS ASN-278 AND MET-292
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter